Hollaender, Norbert http://orcid.org/0000-0003-1031-7397
Glimm, Ekkehard
Gauvin, Jennifer
Stefanelli, Tommaso
Zeiser, Robert http://orcid.org/0000-0001-6565-3393
Funding for this research was provided by:
Novartis
Article History
Received: 17 May 2023
Revised: 31 August 2023
Accepted: 12 October 2023
First Online: 28 October 2023
Competing interests
: NH and TS are current employees of Novartis. EG and JG hold equity in and are current employees of Novartis. RZ received honoraria from and is on the speaker’s bureau for Incyte, Mallinckrodt, and Novartis, and has consulted for Incyte and Novartis.